Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Short-term intraocular pressure trends following intravitreal injections of ranibizumab (Lucentis) for the treatment of wet age-related macular degeneration.

× No keyword cloud information.

11 in total

1. Impact of injection techniques on intraocular pressure (IOP) increase after intravitreal ranibizumab application.

Authors: Fabian Höhn; Alireza Mirshahi
Journal: Graefes Arch Clin Exp Ophthalmol Date: 2010-04-21 Impact factor: 3.117

2. Intraocular pressure decreases in eyes with glaucoma-related diagnoses after conversion to aflibercept for treatment-resistant age-related macular degeneration.

Authors: David J Ramsey; James C McCullum; Elise E Steinberger; Yubo Zhang; Amer Mosa Alwreikat; Michael L Cooper; Shiyoung Roh; Paul R Cotran
Journal: Eye (Lond) Date: 2021-08-12 Impact factor: 4.456

Review 3. Ranibizumab: a review of its use in the treatment of neovascular age-related macular degeneration.

Authors: James E Frampton
Journal: Drugs Aging Date: 2013-05 Impact factor: 3.923

4. Comparative role of intravitreal ranibizumab versus bevacizumab in choroidal neovascular membrane in age-related macular degeneration.

Authors: Partha Biswas; Subhrangshu Sengupta; Ruby Choudhary; Subhankar Home; Ajoy Paul; Sourav Sinha
Journal: Indian J Ophthalmol Date: 2011 May-Jun Impact factor: 1.848

5. Effect of prophylactic timolol 0.1% gel on intraocular pressure after an intravitreal injection of ranibizumab: a randomized study.

Authors: Alfredo Pece; Davide Allegrini; Giovanni Montesano; Andrea Fabio Dimastrogiovanni
Journal: Clin Ophthalmol Date: 2016-06-17

6. Long-term effect of anti-vascular endothelial growth factor injections on intraocular pressure.

Authors: Ashiyana Nariani; Blake Williams; Seenu M Hariprasad
Journal: Indian J Ophthalmol Date: 2016-09 Impact factor: 1.848

7. Effect of prophylactic intraocular pressure-lowering medication (brinzolamide) on intraocular pressure after ranibizumab intravitreal injection: A case-control study.

Authors: Shuang Song; Xiao-Bing Yu; Hong Dai
Journal: Indian J Ophthalmol Date: 2016-10 Impact factor: 1.848

Short-term intraocular pressure trends following intravitreal injections of ranibizumab (Lucentis) for the treatment of wet age-related macular degeneration.